Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|June 20, 2000
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin BJ L Harousseau, A W Dekker, A Stamatoullas-Bastard, et al.
Blood|April 21, 2001
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusionsA Badros, B Barlogie, C Morris, et al.
Bone Marrow Transplantation|August 11, 2001
Collection of hematopoietic stem cells from patients with autoimmune diseasesR K Burt, A Fassas, J Snowden, et al.
Leukemia|January 17, 2009
Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptorsE Kostareli, A Hadzidimitriou, N Stavroyianni, et al.
Blood|June 17, 1998
Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myelomaG Tricot, Y Gazitt, T Leemhuis, et al.
Lupus|December 22, 2012
Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registryB Alchi, D Jayne, M Labopin, et al.
Bone Marrow Transplantation|October 26, 2005
Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myelomaI Gojo, B Meisenberg, C Guo, et al.
Blood|June 14, 2000
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalitiesR Desikan, B Barlogie, J Sawyer, et al.
Blood|December 24, 1998
Total therapy with tandem transplants for newly diagnosed multiple myelomaB Barlogie, S Jagannath, K R Desikan, et al.
Bone Marrow Transplantation|November 2, 2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosisR Saccardi, A Tyndall, G Coghlan, et al.
Pageof 6